Michigan Society Of Hematology And Oncology
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 664,412 | 805,441 | −141,029 | 19.9 | 26% |
| 2012 | 665,454 | 770,154 | −104,700 | 19.2 | 28% |
| 2013 | 563,050 | 576,449 | −13,399 | 25.4 | 39% |
| 2014 | 660,267 | 671,628 | −11,361 | 24.2 | 39% |
| 2015 | 625,855 | 546,191 | 79,664 | 30.9 | 39% |
| 2016 | 793,615 | 601,254 | 192,361 | 32.6 | 39% |
| 2017 | 945,122 | 625,833 | 319,289 | 38.5 | 41% |
| 2018 | 658,950 | 602,349 | 56,601 | 38.8 | 36% |
| 2019 | 887,030 | 643,969 | 243,061 | 42.9 | 35% |
| 2020 | 969,738 | 600,979 | 368,759 | 56.5 | 41% |
| 2021 | 1,023,674 | 663,094 | 360,580 | 59.2 | 37% |
| 2022 | 1,134,631 | 744,602 | 390,029 | 51.9 | 37% |
| 2023 | 1,220,188 | 751,026 | 469,162 | 63.8 | 40% |
In its most recent public year (2023), this organization brought in $469,162 more than it spent. Its reserves stood at about 63.8 months of spending, up from 19.9 in 2011. Staff pay was 40% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Michigan Society Of Hematology And Oncology's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works